BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Novo Nordisk at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Novo Nordisk takes part in 4 sessions at BIO-Europe 2026 in Cologne. Its sessions centre on pharma productivity, the conditions that help biopharma partnerships succeed, longevity research and cardiometabolic medicine beyond GLP-1 drugs. Novo Nordisk also sponsors the meeting.
| Organization | BIO-Europe 2026 Attendance |
|---|---|
Novo Nordisk Bagsværd, Denmark | ◆Gold Sponsor |
Danish pharmaceutical company, branded Novo since September 2026, making medicines for diabetes, obesity and rare diseases. | Panel Mon Nov 9 11:15–12:00 Unlocking Pharma’s Productivity Potential Why developing medicines keeps getting costlier and slower, and whether AI and research sourced from other companies can make drug companies more productive. Business of Biotech Panel Tue Nov 10 15:30–15:55 Accelerating Innovation: Creating the Right Environment for Success in Biopharma Partnerships How to design partnerships that work, from payments tied to research milestones and shared risk to guarding intellectual property while sharing ideas. Panel Tue Nov 10 10:00–10:45 Cardiometabolic innovations beyond GLP-1 – Where are we now? Which drug approaches beyond GLP-1 medicines are drawing attention for obesity, diabetes and heart disease risk, and where money and partnerships are going. Panel Tue Nov 10 15:00–15:45 Longevity – Are we getting younger? What recent research shows about treatments that could slow or reverse aging, and how investment in this young field is taking shape. |
Find decision makers at Novo Nordisk
Tell us what you sell and we’ll find the people at Novo Nordisk most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction